Report
EUR 238.53 For Business Accounts Only

Lannett Company, Inc.: Update to credit analysis following outlook change to stable

Contributions from new product launches and consistent focus on debt repayment will help credit metrics beyond fiscal 2020.
Underlying
Lannett Company Inc.

Lannett Company develops, manufactures, packages, markets, and distributes solid oral and extended release (tablets and capsules), topical, liquids, nasal and oral solution finished dosage forms of drugs, generic forms of both small molecule and biologic medications, that address various therapeutic areas. The company's products are: Levothyroxine Sodium tablets, which are used for the treatment of thyroid deficiency; Fluphenazine tablets, which are used for the management of manifestations of psychotic disorders; Verapamil SR tablets, which are used in the treatment of high blood pressure, arrhythmia and angina; and Ursodiol Capsules, which are used for the treatment and prevention of gallstones.

Provider
Moody's Investors Service
Moody's Investors Service

Moody's Investors Service is a leading provider of credit ratings, research, and risk analysis. Moody's commitment and expertise contributes to transparent and integrated financial markets, protecting the integrity of credit. Our ratings and analysis track debt covering more than:

  • 130 countries
    11,000 corporate issuers
    21,000 public finance issuers
    76,000 structured finance obligations



Credit ratings and research help investors analyze the credit risks associated with fixed-income securities. Such independent credit ratings and research also contribute to efficiencies in fixed-income markets and other obligations, such as insurance policies and derivative transactions, by providing credible and independent assessments of credit risk.



Moody’s default studies validate our predictive ratings. Our published research and investor briefings draw thousands of attendees each year and keep investors current with the rationale underlying our credit opinions. 

Other Reports on these Companies
Other Reports from Moody's Investors Service

ResearchPool Subscriptions

Get the most out of your insights

Get in touch